4.14
price down icon0.72%   -0.03
after-market Handel nachbörslich: 4.11 -0.03 -0.72%
loading
Schlusskurs vom Vortag:
$4.17
Offen:
$4.16
24-Stunden-Volumen:
39,447
Relative Volume:
0.72
Marktkapitalisierung:
$24.00M
Einnahmen:
$5.75M
Nettoeinkommen (Verlust:
$-38.96M
KGV:
-0.332
EPS:
-12.47
Netto-Cashflow:
$-32.63M
1W Leistung:
+11.29%
1M Leistung:
+20.00%
6M Leistung:
-39.03%
1J Leistung:
-36.99%
1-Tages-Spanne:
Value
$3.76
$4.16
1-Wochen-Bereich:
Value
$3.50
$4.40
52-Wochen-Spanne:
Value
$2.92
$11.20

Kala Bio Inc Stock (KALA) Company Profile

Name
Firmenname
Kala Bio Inc
Name
Telefon
781-996-5252
Name
Adresse
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
KALA's Discussions on Twitter

Vergleichen Sie KALA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
KALA
Kala Bio Inc
4.14 24.00M 5.75M -38.96M -32.63M -12.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Kala Bio Inc Stock (KALA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-03-30 Herabstufung JP Morgan Neutral → Underweight
2021-08-06 Herabstufung JP Morgan Overweight → Neutral
2020-09-14 Herabstufung Jefferies Buy → Hold
2020-07-23 Eingeleitet Northland Capital Outperform
2020-06-01 Fortgesetzt Oppenheimer Outperform
2020-05-27 Bestätigt H.C. Wainwright Buy
2020-03-09 Hochstufung BofA/Merrill Neutral → Buy
2019-12-17 Herabstufung BofA/Merrill Buy → Neutral
2019-03-14 Eingeleitet Jefferies Buy
Alle ansehen

Kala Bio Inc Aktie (KALA) Neueste Nachrichten

pulisher
Jun 06, 2025

Millennium Management LLC Decreases Stake in KALA BIO, Inc. (NASDAQ:KALA) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock - Investing.com India

Jun 05, 2025
pulisher
Jun 04, 2025

KALA BIO Executives Sell Shares - TradingView

Jun 04, 2025
pulisher
Jun 03, 2025

KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

KALA: Oppenheimer Announces Outperform Rating for Kala Bio | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Reveal Latest Eye Disease Pipeline Progress at Major Jefferies Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 26, 2025

Q1 Earnings Estimate for KALA BIO Issued By HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

HC Wainwright Lowers KALA BIO (NASDAQ:KALA) Price Target to $12.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Kala Bio stock target cut to $12 by H.C. Wainwright, retains buy - Investing.com Nigeria

May 24, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bi - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bio | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 15, 2025

KALA BIO: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

Persistent Epithelial Defect Market on Track for Major - openPR.com

May 14, 2025
pulisher
May 14, 2025

KALA Focuses on Advancing KPI-012 Development Amid Pivotal Trials | KALA Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025 - The Manila Times

May 14, 2025
pulisher
May 14, 2025

KALA's PCED Drug Could Reach 100,000 PatientsQ3 Trial Results Coming - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Q2 EPS Forecast for Design Therapeutics Reduced by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Datadog Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Cadre Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Equities Analysts Issue Forecasts for Cryoport Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Forecasts Lower Earnings for Denali Therapeutics - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimates for Core Scientific Lifted by HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Fox Factory Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

KALA BIO (KALA) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 Earnings Forecast for Cryoport Issued By Leerink Partnrs - Defense World

May 12, 2025
pulisher
May 11, 2025

KALA BIO (KALA) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Fluence Energy, Inc. (NASDAQ:FLNC) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 08, 2025
pulisher
May 07, 2025

Dimensional Fund Advisors LP Sells 5,772 Shares of Turning Point Brands, Inc. (NYSE:TPB) - Defense World

May 07, 2025
pulisher
May 04, 2025

Head-To-Head Survey: Equillium (NASDAQ:EQ) and KALA BIO (NASDAQ:KALA) - Defense World

May 04, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Has $426,000 Stake in Sidus Space, Inc. (NASDAQ:SIDU) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Boosts Holdings in KALA BIO, Inc. (NASDAQ:KALA) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Has $403,000 Stake in Mobix Labs, Inc. (NASDAQ:MOBX) - Defense World

May 03, 2025
pulisher
Apr 30, 2025

Wix.com Ltd [WIX] Insider Activity: An Update for Investors - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Understanding the Risks of Investing in CureVac N.V (CVAC) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Recent Insider Activity Could Benefit Insperity Inc (NSP) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Analyzing Kala Bio Inc (KALA) After Recent Trading Activity - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

International Business Machines Corp [IBM] Stock sold by Insider Thomas Robert David for $6.72 million - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Aurora Cannabis Inc [ACB] Investment Guide: What You Need to Know - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Insider Sale Alert: Angi Inc [ANGI] – Is it Time to sell? - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Kala Bio Inc (KALA) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Kala Bio Inc (KALA) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com

Apr 30, 2025

Finanzdaten der Kala Bio Inc-Aktie (KALA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Kala Bio Inc-Aktie (KALA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Reumuth Mary
CHIEF FINANCIAL OFFICER
Jun 03 '25
Sale
3.74
2,850
10,659
65,731
Bazemore Todd
SEE REMARKS
Jun 03 '25
Sale
3.74
3,390
12,679
87,757
Brazzell Romulus K
SEE REMARKS
Jun 03 '25
Sale
3.74
3,687
13,789
87,949
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):